Age category
|
Risk category
|
Cancer yielda (95% CI)
|
FPRa (95% CI)
|
FPBa (95% CI)
|
---|
A. Mammography
|
< 40 years
|
Overall
|
6.54 (3.73–11.46)
|
36.06 (27.57–47.03)
|
19.48 (13.73–27.58)
|
BRCA
|
7.17 (3.61–14.18)
|
26.96 (18.07–40.03)
|
15.52 (9.03–26.57)
|
No BRCA
|
5.61 (2.10–14.89)
|
49.62 (34.62–70.64)
|
24.94 (15.94–38.83)
|
40–50 years
|
Overall
|
6.35 (3.71–10.83)
|
40.44 (31.53–51.72)
|
24.23 (17.66–33.16)
|
BRCA
|
6.78 (2.85–16.02)
|
18.90 (11.26–31.56)
|
12.21 (6.37–23.30)
|
No BRCA
|
6.11 (3.08–12.06)
|
52.66 (39.80–69.38)
|
30.56 (21.36–43.55)
|
50–60 years
|
Overall
|
13.57 (9.21–19.94)
|
33.28 (24.94–44.29)
|
18.38 (12.60–26.75)
|
BRCA
|
26.10 (15.93–42.47)
|
10.56 (4.75–23.31)
|
8.85 (3.67–21.15)
|
No BRCA
|
7.89 (4.26–14.58)
|
43.06 (31.68–58.27)
|
22.16 (14.61–33.47)
|
≥ 60 years
|
Overall
|
17.72 (10.81–28.93)
|
25.82 (16.76–39.58)
|
10.88 (5.64–20.90)
|
BRCA
|
21.48 (7.99–56.49)
|
10.69 (2.64–42.22)
|
0.00 (N/A)
|
No BRCA
|
16.90 (9.54–29.77)
|
30.38 (19.27–47.57)
|
14.14 (7.31–27.15)
|
Overall
|
Overall
|
9.95 (7.80–12.69)
|
36.42 (31.42–42.19)
|
20.05 (16.49–24.37)
|
BRCA
|
12.44 (8.75–17.65)
|
20.65 (15.32–27.77)
|
12.56 (8.50–18.51)
|
No BRCA
|
8.33 (5.95–11.65)
|
47.08 (39.74–55.71)
|
24.95 (19.91–31.24)
|
B. MRI
|
< 40 years
|
Overall
|
13.09 (8.80–19.44)
|
87.25 (74.68–101.71)
|
62.30 (51.89–74.63)
|
BRCA
|
14.31 (8.81–23.16)
|
75.49 (60.59–93.70)
|
56.72 (44.03–72.79)
|
No BRCA
|
11.22 (5.61–22.31)
|
104.96 (84.38–129.84)
|
70.70 (54.44–91.35)
|
40–50 years
|
Overall
|
14.06 (9.83–20.07)
|
70.45 (59.44–83.31)
|
55.95 (46.39–67.33)
|
BRCA
|
18.86 (11.26–31.42)
|
47.03 (34.06–64.61)
|
34.73 (23.93–50.15)
|
No BRCA
|
11.37 (6.91–18.66)
|
82.49 (67.63–100.27)
|
67.55 (54.44–83.53)
|
50–60 years
|
Overall
|
19.56 (14.16–26.96)
|
41.64 (32.53–53.16)
|
29.88 (22.29–39.94)
|
BRCA
|
40.37 (27.00–59.96)
|
44.36 (29.42–66.36)
|
30.66 (18.27–51.02)
|
No BRCA
|
10.25 (5.97–17.55)
|
40.08 (29.42–54.38)
|
29.41 (20.59–41.84)
|
≥ 60 years
|
Overall
|
23.56 (15.39–35.93)
|
29.04 (19.45–43.15)
|
20.49 (12.72–32.85)
|
BRCA
|
21.48 (7.99–56.49)
|
10.85 (2.66–43.12)
|
10.85 (2.66–43.12)
|
No BRCA
|
24.40 (15.23–38.87)
|
34.37 (22.63–51.89)
|
23.31 (14.04–38.45)
|
Overall
|
Overall
|
16.64 (13.81–20.04)
|
62.52 (56.37–69.29)
|
46.27 (41.11–52.06)
|
BRCA
|
22.08 (17.03–28.60)
|
56.98 (48.07–67.42)
|
41.81 (34.35–50.80)
|
No BRCA
|
13.10 (10.02–17.10)
|
66.13 (58.03–75.27)
|
49.21 (42.42–57.03)
|
C. Combination
|
< 40 years
|
Overall
|
13.56 (9.24–20.10)
|
99.78 (86.35–115.04)
|
65.68 (54.96–78.31)
|
BRCA
|
14.31 (8.81–23.16)
|
85.01 (69.45–103.66)
|
60.34 (47.29–76.70)
|
No BRCA
|
12.65 (6.58–24.21)
|
121.64 (99.00–148.59)
|
73.85 (56.96–95.26)
|
40–50 years
|
Overall
|
15.02 (10.64–21.17)
|
89.74 (77.29–103.98)
|
63.26 (53.13–75.18)
|
BRCA
|
18.86 (11.26–31.42)
|
57.42 (42.61–76.97)
|
42.39 (29.86–59.85)
|
No BRCA
|
12.89 (8.10–20.48)
|
107.19 (90.27–126.84)
|
74.68 (61.11–90.97)
|
50–60 years
|
Overall
|
23.82 (17.82–31.76)
|
60.11 (48.79–73.85)
|
36.58 (28.05–47.59)
|
BRCA
|
45.29 (31.14–65.43)
|
47.62 (32.20–69.90)
|
33.91 (20.91–54.54)
|
No BRCA
|
14.16 (8.97–22.29)
|
65.53 (51.26–83.42)
|
37.51 (27.28–51.37)
|
≥ 60 years
|
Overall
|
26.49 (17.31–40.36)
|
46.86 (34.05–64.17)
|
24.16 (15.57–37.33)
|
BRCA
|
21.48 (7.99–56.49)
|
22.05 (8.12–58.46)
|
10.85 (2.66–43.12)
|
No BRCA
|
27.87 (17.39–44.38)
|
54.21 (38.71–75.43)
|
28.06 (17.67–44.30)
|
Overall
|
Overall
|
18.68 (15.65–22.27)
|
79.65 (72.70–87.21)
|
51.73 (46.28–57.78)
|
BRCA
|
23.17 (18.00–29.79)
|
65.59 (56.09–76.55)
|
46.14 (38.31–55.47)
|
No BRCA
|
15.74 (12.28–20.15)
|
89.14 (79.65–99.64)
|
55.39 (48.20–63.57)
|
- aGeneral estimating equations were used to calculate performance measures, correcting for multiple screening rounds within the same patient. All measurements are per 1000 examinations
- MRI magnetic resonance imaging, N/A no cancers, recalls, or biopsies were found in this category and no 95% CI of this measure could be calculated, 95% CI Wald 95% confidence intervals